Improving blood safety in resource-poor settings

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Lee, Helen H ^a,b   Allain, J P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Cambridge Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD TRANSFUSION; CONFERENCE PAPER; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PRIORITY JOURNAL; SCREENING;

BLOOD BANKS; BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; HEALTH RESOURCES; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; POVERTY; SAFETY;

EID: 4444300927     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Schmidt PJ: US blood safety. Transfusion Today 1997; 32:10
2. Blood supply FDA oversight and remaining issues of safety: GAP/ PEMD 97-1. Washington DC, US General Accounting Office, 1997
3. English M, Ahmed M, Ngando C, Berkley J, Ross A: Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 2002; 359:494-5
4. World Health Organisation, Blood Transfusion Service: Global database on blood safety from 1998-1999. Geneva, WHO/BTS, 2001 Summary report.
5. Lackritz EM: Prevention of HIV transmission by blood transfusion in the developing world: Achievements and continuing challenges. AIDS 1998; 12:S81-6
6. Ndumbe PM, Nyouma E: Transmission of hepatitis B virus by blood transfusion in Yaounde, Cameroon. BMJ 1990; 301:523-4
7. Sarkodie F, Adarkwa M, Sarkodie Y, Acheampong JW, Allain JP: Screening for viral markers by EIA in volunteer and replacement donors in Kumasi. Ghana Vox Sanguinis 2001; 80:142-7
8. Saha V, John TJ, Dhamodaran S, Carman RH: Highly sensitive screening tests for hepatitis B surface antigen in transfusion centres of developing countries. BMJ 1988; 297:334-5
9. Opare-Sem O, Owusu-Ofori S, Allain JP: A novel approach to blood safety: Pre-donation screening of blood donors for viral markers. Africa Sanguine 2002; 5:12-6
10. World Health Organisation UNAIDS: HIV Simple/Rapid Assays: Operational Characteristics (Phase I). Geneva, 2002 WHO/BCT/ 02.07 Report 12
11. World Health Organisation, Blood Safety and Clinical Technology, Blood Transfusion Safety: Hepatitis B Surface Antigen Assays. Operational Characteristics (Phase I) Blood Safety and Clinical Technology. Geneva, WHO, /BCT/BTS/ 2001:01.2
12. Apetrei C, Loussert-Ajaka I, Descamps D, Damond F, Saragosti S, Brun-Vezinet F, Simon F: Lack of screening test sensitivity during HIV-1 non-subtype B seroconversion. AIDS 1996; 10:F57-F60
13. Thorstensson R, Andersson S, Lindback S, Dias F, Mhalu F, Gaines H, Biberfeld G: Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Meth 1998; 70:139-51
14. Constantine NT, Zekeng L, Sangare AK, Gurtler L, Saville R, Anhary H, Wild C: Diagnostic challenges for rapid human immuno-deficiency virus assays: Performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples. J Hum Virol 1997; 1:45-51
15. Makuwa M, Souquiere S, Niangui M-T, Rouquet P, Apetrei C, Roques P, Simon F. Reliability of rapid diagnostic tests for HIV variant infection. J Virol Meth 2002; 103:183-90
16. Allain JP, Candotti D, Soldan K, Sarkodie F, Pheips B, Giachetti C, Shyamala V, Yeboah F, Anokwa M, Owusu-Ofori S, Opare-Sem O: The risk of hepatitis B virus infection in Kumasi, Ghana. Blood 2003; 101:2419-25